SYNTERACT HCR LIMITED

Dissolved Farnborough
64 employees website.com
S

SYNTERACT HCR LIMITED

Founded 15 Feb 1991 Dissolved Farnborough, United Kingdom 64 employees website.com

Previous Company Names

HARRISON CLINICAL RESEARCH LIMITED 15 Feb 1991 — 6 Aug 2013
Accounts Submitted 4 Oct 2023
Confirmation Submitted 26 Mar 2024 Next due 1 Mar 2025 14 months overdue
Net assets £2M £354K 2022 year on year
Total assets £2M £82K 2022 year on year
Total Liabilities £198K £273K 2022 year on year
Charges 2
2 outstanding

Contact & Details

Contact

Registered Address

1 Pinehurst Road Farnborough Business Park Farnborough Hampshire GU14 7BF United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for SYNTERACT HCR LIMITED (02582852), a dissolved company based in Farnborough, United Kingdom. Incorporated 15 Feb 1991. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2022
Type Total Exemption Full
Next accounts 31 December 2023
Due by 30 September 2024 9 months

Net Assets, Total Assets & Total Liabilities (2013–2022)

Cash in Bank

£857.64k

Increased by £480.49k (+127%)

Net Assets

£1.82M

Increased by £354.28k (+24%)

Total Liabilities

£198.07k

Decreased by £272.56k (-58%)

Turnover

£4.83M

Decreased by £1.06M (-18%)

Employees

64

Decreased by 10 (-14%)

Debt Ratio

10%

Decreased by 14 (-58%)

Financial History

Revenue, profit, EBITDA and key financial figures

2022
Dec Year End
2021
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Nyla Natalie Donna Maria SinghDirectorBritishUnited Kingdom633 Feb 2021Active

Shareholders

Shareholders (1)

Synteracthcr Group Gmbh
100.0%
67

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 17 May 2023
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Syneos Health, Inc.

Ceased 17 May 2023

Ceased

Group Structure

Group Structure

SYNTERACT HCR LIMITED Current Company

Charges

Charges

2 outstanding

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Oct 2024GazetteGazette Dissolved Voluntary
6 Aug 2024GazetteGazette Notice Voluntary
24 Jul 2024DissolutionDissolution Application Strike Off Company
26 Mar 2024Confirmation StatementConfirmation statement made on 2024-02-15 with no updates
4 Oct 2023Persons With Significant ControlCessation of Syneos Health, Inc. as a person with significant control on 2023-05-17
22 Oct 2024 Gazette

Gazette Dissolved Voluntary

6 Aug 2024 Gazette

Gazette Notice Voluntary

24 Jul 2024 Dissolution

Dissolution Application Strike Off Company

26 Mar 2024 Confirmation Statement

Confirmation statement made on 2024-02-15 with no updates

4 Oct 2023 Persons With Significant Control

Cessation of Syneos Health, Inc. as a person with significant control on 2023-05-17

Recent Activity

Latest Activity

Gazette Dissolved Voluntary

1 years ago on 22 Oct 2024

Gazette Notice Voluntary

1 years ago on 6 Aug 2024

Dissolution Application Strike Off Company

1 years ago on 24 Jul 2024

Confirmation statement made on 2024-02-15 with no updates

2 years ago on 26 Mar 2024

Cessation of Syneos Health, Inc. as a person with significant control on 2023-05-17

2 years ago on 4 Oct 2023